Navigation Links
drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007
Date:2/6/2008

ng activities:

Purchases of marketable

securities (11,004) (4,822) (27,544) (22,853)

Sales and maturities of

marketable securities 21,316 4,700 37,141 21,775

Purchases of fixed

assets (3,466) (2,020) (14,249) (7,564)

Purchases of intangible

assets - - (456) -

Net cash provided by

(used in) investing

activities 6,846 (2,142) (5,108) (8,642)

Financing activities:

Proceeds from exercise of

stock options and

employee stock purchase

plan 985 1,319 4,366 2,716

Proceeds from line of

credit, term loan and

asset financings 3,700 1,325 4,000 2,325

Principal payments on

line of credit, capital

lease and term loan

obligations (3,667) (497) (5,857) (2,214)

Net cash provided by

financing activities 1,018 2,147 2,509 2,827

Net increase

(decrease) in

cash and cash

equivalents 8,610 (99) 5,179 (6,898)

Cash and cash

equivalents,

beginning of period 9,962 13,492 13,393 20,291

Cash and cash

equivalents, end of

period $18,572 $13,393 $18,572 $13,393


'/>"/>
SOURCE drugstore.com, inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007
2. drugstore.com, inc. to Announce Third Quarter 2007 Results During Conference Call on Monday, October 22, 2007 at 5:00 p.m. ET
3. drugstore.com and Revolution Health Group Announce Breakthrough Deal
4. TyraTech Achieves Insecticide Development and Financial Milestones With Partner Arysta LifeScience
5. Joint Commission International Achieves Accreditation from ISQua
6. Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia
7. Halogen Software Achieves Most Successful Quarter in Company History - Includes Record Year-Over-Year Overall and License Revenue
8. Pharsight Achieves $7.3 Million in Quarterly Revenue
9. ENDEAVOR IV achieves primary endpoint, demonstrates similar safety profile compared to Taxus stent
10. LMS integrated obstetrics solution achieves general availability
11. OSF HealthCare Achieves Impressive Tobacco Quit Rates with the Free & Clear(R) Quit For Life(TM) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...t-traumatic stress disorder (PTSD) affects as many...rowing experience like rape, assault, war or terro...11 and broken up survivors, families. , There i... chance of developing the disorder, but thanks to ...of preventing PTSD may be just around the corner. ...
(Date:12/1/2008)...RIA, Va., Dec. 1 Today,... nearly 7,000 people die each day due to HIV/AID... of awareness and outreach to help people worldwid...me for World AIDS Day 2008 is You Can Make a Dif...ing people together to talk about HIV as well as h...
(Date:12/1/2008)..., Dec. 1 Blue Cross Blue Shield of...d financial and membership information,today to M...quest for further,information about Michigan,s in...n confirms growth of Michigan,s individual health ...suffered by BCBSM, the state,s last-resort,insura...
(Date:12/1/2008)..., Dec. 1 Condell Health...nter, a 283-bed hospital in Libertyville - after v...dicare and Medicaid payments - has agreed without ...of Illinois$36 million as a result of filing false...tzgerald, U.S. Attorney for the Northern District ...
Breaking Medicine News(10 mins):Health News:Easing the stress of trauma 2Health News:In Support of World AIDS Day, FHSSA Announces New Partnerships That Include the First In-Country Partnerships in Namibia and The Gambia 2Health News:Blue Cross Blue Shield of Michigan Answers Attorney General 2Health News:Blue Cross Blue Shield of Michigan Answers Attorney General 3Health News:Condell Health Network and Medical Center to Pay $36 Million Settlement After Self-Reporting Possible Health-Care Fraud 2
...erous health benefits and is being touted as a new...is welcome.Nicolas G. Bazan, MD, PhD, Boyd Profess...xcellence at LSU Health Sciences Centre in New Orl...ga-3 fatty acids in fish oil play in protecting ce...
...n increase in the number of babies born in the hou...d there were 15,198 home births// in 2004. The gro...ia had the lowest rates of home birth, and Devon h...d that women could not have a home birth. Even doc...
...preliminary study in humans are to be believed, re...nd out as part of a research// which appears in th...ion. In a statement by co-author Dr. Eric Ravussi...Baton Rouge, "A lot of evidence already exists to ...
...seas doctors in Britain are alarmed as new rules ...work permit before they can work// in hospitals of...rrently thousands of doctors from the Indian subc...selves unemployed. In the event of a job vacancy i...
Other Medicine News:Health News:Cut down on food to live longer!!! 2Health News:Work Permit Required For Indian Doctors in Britain 2Health News:Work Permit Required For Indian Doctors in Britain 3
(Date:11/27/2008)... of acute lymphoblastic leukemia relapse cases ari...nosis , , MEMPHIS, Tenn., Nov. 27 /PRNewswi...s Research Hospital have identified distinctive ge... acute lymphoblastic leukemia (ALL) that cause rel...eatments for ALL relapse in children and, ultimate...
(Date:11/26/2008)...ts , , FRANKLIN, Mass., Nov. 26 /PRNewswire...d: PLCSF) announced today that it has received ful...ion (FDA) for its U.S. pivotal trial to study the ...M) and associated therapy in the prevention of Co...DA also approved PLC,s request to expand their inv...
(Date:11/25/2008)...nts against expanding statin use broadly in wake o...., Nov. 25 JUPITER, a clinical tri...cular risk of healthy patients with elevated CRP, ...ults, according to a national poll directed at hea...rt in the online poll conducted by medical news si...
(Date:11/25/2008)...PRNewswire-FirstCall/ -- Pharmacyclics, Inc.,(Nas... completed a Phase 1,clinical trial with PCI-2748...cule Factor VIIa inhibitor. The trial was conducte...the safety and pharmacologic effect of,PCI-27483....a linear dose,response in the International Norma...
Breaking Medicine Technology:St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Choose Biodegradable Sunscreen to Save Coral Reefs 11459 1Choose Biodegradable Sunscreen to Save Coral Reefs 11459 2U S on Sidelines as Nations Launch Negotiations on Treaty to Combat Smuggling Counterfeiting and Other Illicit Trade in Tobacco Products 11455 1U S on Sidelines as Nations Launch Negotiations on Treaty to Combat Smuggling Counterfeiting and Other Illicit Trade in Tobacco Products 11455 2U S on Sidelines as Nations Launch Negotiations on Treaty to Combat Smuggling Counterfeiting and Other Illicit Trade in Tobacco Products 11455 3Predictors of inaccurate online breast cancer information 11452 1Predictors of inaccurate online breast cancer information 11452 2How red blood cells nuke their nuclei 11448 1How red blood cells nuke their nuclei 11448 2
...rmaceutical Co, Ltd. Sponsored Study,Presented at ...g -, SAN DIEGO, May 23, 2007 /PRNewswire/ -- In a ...ith schizophrenia, the Otsuka,Pharmaceutical Co., ...ipsychotic aripiprazole demonstrated significant i...cacy endpoint, Positive and,Negative Syndrome Scal...
...se 1 Studies with Monoclonal Antibody,Targeting In...er,Rationale for IL-9 Inhibition in Developing Pot..., 2007 /PRNewswire-FirstCall/ --,MedImmune, Inc. t...ng recent progress within the company,s inflammato...ase 1 clinical,studies with its monoclonal antibod...
Other Medicine Technology:Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 2Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 3Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 4Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 5Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 6Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 7Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 8Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 9MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 2MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 3MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 4MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 5MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 6MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 7
...-I or somatomedin C) is a 7.6 kDa peptide produced...en of cellular proliferation, exerting its actions... the circulation, IGF-I is bound to IGF-binding pr...ons of IGF-I by modulating the interaction of IGF-...
...-I or somatomedin C) is a 7.6 kDa peptide produced...en of cellular proliferation, exerting its actions... the circulation, IGF-I is bound to IGF-binding pr...ons of IGF-I by modulating the interaction of IGF-...
...-I or somatomedin C) is a 7.6 kDa peptide produced...en of cellular proliferation, exerting its actions... the circulation, IGF-I is bound to IGF-binding pr...ons of IGF-I by modulating the interaction of IGF-...
... potent naturally occurring androgen produced from...a-reductase [1]. The concentrations of 5a-reducta...uding genital skin and hair follicles, and are loc...th the nuclear membrane. DHT exerts its biologica...
Medicine Products: